• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIABETIC CARE, INC. FREESTYLE LIBRE 3 SENSOR; SENSOR, GLUCOSE, INVASIVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIABETIC CARE, INC. FREESTYLE LIBRE 3 SENSOR; SENSOR, GLUCOSE, INVASIVE Back to Search Results
Model Number 3 57599 81800 5
Device Problems Product Quality Problem (1506); Failure to Transmit Record (1521); Failure to Sense (1559); Defective Component (2292); Detachment of Device or Device Component (2907); Activation Failure (3270)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/17/2023
Event Type  malfunction  
Event Description
I was prescribed freestyle libre 3 in (b)(6) 2022 and have used it almost continuously since then.The device is designed to have a two week lifespan, after which it must be replaced.Notwithstanding that i have carefully followed all the prerequisites for application and use, i have experienced: multiple failures to send data, sensors falling off the arm, sensors not working, sensors that do not stick when applied and, a sensor that failed to deploy at all.Abbott has replaced 10 sensors in this nearly 6 month period, in which, at most, i would have used 13, a failure rate of 77% due to, in my opinion, shoddy manufacturing.On saturday, (b)(6) 2023, abbott compounded their sorry performance by informing us they would not replace any more sensors.They are at fault and we have to pay for the abysmal quality of their devices,, if we wish to continue to use the device our endocrinologist has prescribed.They informed us they would not permit us to reach anyone in higher authority in order to attempt to rectify the situation.During the 6 months, i several times offered to send them back the defective part, but they mostly refused.I think a manufacturer of a medical device should be made to stand behind the product they are allowed to sell and should be bound by the local laws concerning warranties of fitness for a particular purpose and merchantability and not be permitted to arbitrarily decide that "10 is too much" when 10 have failed through no fault of the patient and entirely the fault of the manufacturer.If there are any other or further details you would like or require, please do not hesitate to reach out to my spouse, who will be glad to cooperate to the fullest extent possible.Reference report: mw5118765; mw5118766; mw5118767; mw5118768; mw5118769; mw5118770; mw5118771; mw5118772; mw5118773.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE LIBRE 3 SENSOR
Type of Device
SENSOR, GLUCOSE, INVASIVE
Manufacturer (Section D)
ABBOTT DIABETIC CARE, INC.
MDR Report Key17198595
MDR Text Key317919640
Report NumberMW5118764
Device Sequence Number1
Product Code MDS
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 06/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/23/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Expiration Date12/31/2023
Device Model Number3 57599 81800 5
Device Lot NumberT60000991
Was Device Available for Evaluation? Yes
Patient Sequence Number1
Treatment
AMLODIPINE; BUPROPRION; CRESTOR; ELIQUIS; JARDIANCE; KEPPRA; METOPROLOL TARTRATE; MODAFINIL; MONTELUKAST; PEPCID; PIOGLITIZONE; PRESERVISION; SYNTHROID; TUEJEO INSULINE GLARGINE; VITAMIN D 50,000 IU ONCE EVERY 2 WEEKS, BY RX, ; ZETIA
Patient Outcome(s) Other;
Patient Age88 YR
Patient SexFemale
Patient Weight52 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-